Evaluating the iron chelator function of sirtinol in non-small cell lung cancer.

Petronek, Michael S; Bayanbold, Khaliunaa; Amegble, Koffi; Tomanek-Chalkley, Ann M; Allen, Bryan G; Spitz, Douglas R; Bailey, Charvann K

Petronek, Michael S; Bayanbold, Khaliunaa; Amegble, Koffi; Tomanek-Chalkley, Ann M; Allen, Bryan G; Spitz, Douglas R; Bailey, Charvann K.

Affiliation

Petronek MS; Department of Radiation Oncology, Division of Free Radical and Radiation Biology, University of Iowa, Iowa City, IA, United States.
Bayanbold K; Department of Radiation Oncology, Division of Free Radical and Radiation Biology, University of Iowa, Iowa City, IA, United States.
Amegble K; Department of Biology, Grinnell College, Grinnell, IA, United States.
Tomanek-Chalkley AM; Department of Radiation Oncology, Division of Free Radical and Radiation Biology, University of Iowa, Iowa City, IA, United States.
Allen BG; Department of Radiation Oncology, Division of Free Radical and Radiation Biology, University of Iowa, Iowa City, IA, United States.
Spitz DR; Department of Radiation Oncology, Division of Free Radical and Radiation Biology, University of Iowa, Iowa City, IA, United States.
Bailey CK; Department of Biology, Grinnell College, Grinnell, IA, United States.

Front Oncol ; 13: 1185715, 2023.

Article de En | MEDLINE | ID: mdl-37397370

Mots clés

cancer biology; cancer therapy; iron; iron metabolism; non-small cell lung cancer (NSCLC)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Oncol Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google